ID   KAT1_HUMAN              Reviewed;         422 AA.
AC   Q16773; Q5T275; Q8N191;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-APR-2017, entry version 150.
DE   RecName: Full=Kynurenine--oxoglutarate transaminase 1;
DE            EC=2.6.1.7;
DE   AltName: Full=Cysteine-S-conjugate beta-lyase;
DE            EC=4.4.1.13;
DE   AltName: Full=Glutamine transaminase K;
DE            Short=GTK;
DE   AltName: Full=Glutamine--phenylpyruvate transaminase;
DE            EC=2.6.1.64;
DE   AltName: Full=Kynurenine aminotransferase 1 {ECO:0000312|HGNC:HGNC:1564};
DE   AltName: Full=Kynurenine aminotransferase I;
DE            Short=KATI;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase I;
GN   Name=KYAT1 {ECO:0000312|HGNC:HGNC:1564}; Synonyms=CCBL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=7883047; DOI=10.1016/0014-5793(95)00123-Q;
RA   Perry S., Harries H., Scholfield C., Lock E., King L., Gibson G.,
RA   Goldfarb P.;
RT   "Molecular cloning and expression of a cDNA for human kidney cysteine
RT   conjugate beta-lyase.";
RL   FEBS Lett. 360:277-280(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   PHOSPHATE AND PHENYLALANINE, SUBUNIT, AND COFACTOR.
RX   PubMed=15364907; DOI=10.1074/jbc.M409291200;
RA   Rossi F., Han Q., Li J., Li J., Rizzi M.;
RT   "Crystal structure of human kynurenine aminotransferase I.";
RL   J. Biol. Chem. 279:50214-50220(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEXES WITH PYRIDOXAL
RP   PHOSPHATE AND THE INHIBITORS INDOLEACETIC ACID AND TRIS, FUNCTION,
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, AND COFACTOR.
RX   PubMed=19338303; DOI=10.1021/jm9000874;
RA   Han Q., Robinson H., Cai T., Tagle D.A., Li J.;
RT   "Structural insight into the inhibition of human kynurenine
RT   aminotransferase I/glutamine transaminase K.";
RL   J. Med. Chem. 52:2786-2793(2009).
CC   -!- FUNCTION: Catalyzes the irreversible transamination of the L-
CC       tryptophan metabolite L-kynurenine to form kynurenic acid (KA).
CC       Metabolizes the cysteine conjugates of certain halogenated alkenes
CC       and alkanes to form reactive metabolites. Catalyzes the beta-
CC       elimination of S-conjugates and Se-conjugates of L-
CC       (seleno)cysteine, resulting in the cleavage of the C-S or C-Se
CC       bond. {ECO:0000269|PubMed:19338303}.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + 2-oxoglutarate = 4-(2-
CC       aminophenyl)-2,4-dioxobutanoate + L-glutamate.
CC       {ECO:0000269|PubMed:19338303}.
CC   -!- CATALYTIC ACTIVITY: L-glutamine + phenylpyruvate = 2-
CC       oxoglutaramate + L-phenylalanine. {ECO:0000269|PubMed:19338303}.
CC   -!- CATALYTIC ACTIVITY: An L-cysteine-S-conjugate + H(2)O = RSH +
CC       NH(3) + pyruvate. {ECO:0000269|PubMed:19338303}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:15364907,
CC         ECO:0000269|PubMed:19338303};
CC   -!- ENZYME REGULATION: Inhibited by tryptophan, indole-3-pyruvic acid,
CC       3-indolepropionic acid, DL-indole-3-lactic acid, indole-3-acetic
CC       acid (IAC) and Tris. {ECO:0000269|PubMed:19338303}.
CC   -!- PATHWAY: Amino-acid degradation; L-kynurenine degradation;
CC       kynurenate from L-kynurenine: step 1/2.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15364907}.
CC   -!- INTERACTION:
CC       Q15645:TRIP13; NbExp=3; IntAct=EBI-10238309, EBI-358993;
CC       Q08AM6:VAC14; NbExp=3; IntAct=EBI-10238309, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16773-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16773-2; Sequence=VSP_009875;
CC       Name=3;
CC         IsoId=Q16773-3; Sequence=VSP_009876, VSP_009877;
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X82224; CAA57702.1; -; mRNA.
DR   EMBL; AL441992; CAI15414.1; -; Genomic_DNA.
DR   EMBL; AL441992; CAI15415.1; -; Genomic_DNA.
DR   EMBL; BC021262; AAH21262.1; -; mRNA.
DR   EMBL; BC033685; AAH33685.1; -; mRNA.
DR   CCDS; CCDS43884.1; -. [Q16773-1]
DR   CCDS; CCDS48038.1; -. [Q16773-2]
DR   PIR; S69001; S52790.
DR   RefSeq; NP_001116143.1; NM_001122671.1. [Q16773-1]
DR   RefSeq; NP_001116144.1; NM_001122672.1. [Q16773-2]
DR   RefSeq; NP_004050.3; NM_004059.4. [Q16773-1]
DR   RefSeq; XP_011517470.1; XM_011519168.1. [Q16773-1]
DR   RefSeq; XP_011517471.1; XM_011519169.1. [Q16773-1]
DR   RefSeq; XP_011517472.1; XM_011519170.2. [Q16773-1]
DR   RefSeq; XP_016870754.1; XM_017015265.1. [Q16773-1]
DR   RefSeq; XP_016870755.1; XM_017015266.1. [Q16773-1]
DR   RefSeq; XP_016870756.1; XM_017015267.1. [Q16773-1]
DR   RefSeq; XP_016870757.1; XM_017015268.1. [Q16773-1]
DR   UniGene; Hs.495250; -.
DR   PDB; 1W7L; X-ray; 2.00 A; A=1-422.
DR   PDB; 1W7M; X-ray; 2.70 A; A=1-422.
DR   PDB; 1W7N; X-ray; 2.90 A; A=1-422.
DR   PDB; 3FVS; X-ray; 1.50 A; A/B=1-422.
DR   PDB; 3FVU; X-ray; 1.55 A; A/B=1-422.
DR   PDB; 3FVX; X-ray; 1.50 A; A/B=1-422.
DR   PDB; 4WLH; X-ray; 1.28 A; A/B=1-422.
DR   PDB; 4WLJ; X-ray; 1.54 A; A/B=1-422.
DR   PDB; 4WP0; X-ray; 3.00 A; A/B/C/D=1-422.
DR   PDBsum; 1W7L; -.
DR   PDBsum; 1W7M; -.
DR   PDBsum; 1W7N; -.
DR   PDBsum; 3FVS; -.
DR   PDBsum; 3FVU; -.
DR   PDBsum; 3FVX; -.
DR   PDBsum; 4WLH; -.
DR   PDBsum; 4WLJ; -.
DR   PDBsum; 4WP0; -.
DR   ProteinModelPortal; Q16773; -.
DR   SMR; Q16773; -.
DR   BioGrid; 107326; 11.
DR   IntAct; Q16773; 2.
DR   STRING; 9606.ENSP00000302227; -.
DR   BindingDB; Q16773; -.
DR   ChEMBL; CHEMBL3962; -.
DR   DrugBank; DB07950; 1H-INDOL-3-YLACETIC ACID.
DR   DrugBank; DB02556; D-Phenylalanine.
DR   DrugBank; DB00130; L-Glutamine.
DR   DrugBank; DB04083; N'-Pyridoxyl-Lysine-5'-Monophosphate.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB02142; Pyridoxamine-5'-Phosphate.
DR   GuidetoPHARMACOLOGY; 1445; -.
DR   iPTMnet; Q16773; -.
DR   PhosphoSitePlus; Q16773; -.
DR   BioMuta; CCBL1; -.
DR   DMDM; 46396284; -.
DR   EPD; Q16773; -.
DR   MaxQB; Q16773; -.
DR   PaxDb; Q16773; -.
DR   PeptideAtlas; Q16773; -.
DR   PRIDE; Q16773; -.
DR   Ensembl; ENST00000302586; ENSP00000302227; ENSG00000171097. [Q16773-1]
DR   Ensembl; ENST00000320665; ENSP00000317342; ENSG00000171097. [Q16773-2]
DR   GeneID; 883; -.
DR   KEGG; hsa:883; -.
DR   UCSC; uc004bwh.5; human. [Q16773-1]
DR   CTD; 883; -.
DR   DisGeNET; 883; -.
DR   GeneCards; KYAT1; -.
DR   H-InvDB; HIX0008439; -.
DR   HGNC; HGNC:1564; KYAT1.
DR   HPA; HPA021176; -.
DR   HPA; HPA021177; -.
DR   HPA; HPA027736; -.
DR   MIM; 600547; gene.
DR   neXtProt; NX_Q16773; -.
DR   OpenTargets; ENSG00000171097; -.
DR   PharmGKB; PA26138; -.
DR   eggNOG; KOG0257; Eukaryota.
DR   eggNOG; COG0436; LUCA.
DR   GeneTree; ENSGT00650000093238; -.
DR   HOVERGEN; HBG008391; -.
DR   InParanoid; Q16773; -.
DR   KO; K00816; -.
DR   PhylomeDB; Q16773; -.
DR   TreeFam; TF105482; -.
DR   BioCyc; MetaCyc:HS10240-MONOMER; -.
DR   BRENDA; 2.6.1.7; 2681.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   Reactome; R-HSA-71182; Phenylalanine and tyrosine catabolism.
DR   Reactome; R-HSA-71240; Tryptophan catabolism.
DR   UniPathway; UPA00334; UER00726.
DR   ChiTaRS; CCBL1; human.
DR   EvolutionaryTrace; Q16773; -.
DR   GeneWiki; CCBL1; -.
DR   GenomeRNAi; 883; -.
DR   PRO; PR:Q16773; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000171097; -.
DR   CleanEx; HS_CCBL1; -.
DR   ExpressionAtlas; Q16773; baseline and differential.
DR   Genevisible; Q16773; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0047804; F:cysteine-S-conjugate beta-lyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047316; F:glutamine-phenylpyruvate transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016212; F:kynurenine-oxoglutarate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0047945; F:L-glutamine:pyruvate aminotransferase activity; EXP:Reactome.
DR   GO; GO:0047312; F:L-phenylalanine:pyruvate aminotransferase activity; EXP:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; TAS:ProtInc.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006575; P:cellular modified amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0070189; P:kynurenine metabolic process; IDA:UniProtKB.
DR   GO; GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome.
DR   GO; GO:0006569; P:tryptophan catabolic process; TAS:Reactome.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR034614; KAT_I.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   PANTHER; PTHR43807:SF21; PTHR43807:SF21; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aminotransferase;
KW   Complete proteome; Cytoplasm; Lyase; Pyridoxal phosphate;
KW   Reference proteome; Transferase.
FT   CHAIN         1    422       Kynurenine--oxoglutarate transaminase 1.
FT                                /FTId=PRO_0000123942.
FT   BINDING      36     36       Substrate; via amide nitrogen.
FT   BINDING     185    185       Substrate.
FT   BINDING     398    398       Substrate.
FT   MOD_RES     247    247       N6-(pyridoxal phosphate)lysine.
FT   VAR_SEQ      68    117       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009875.
FT   VAR_SEQ     230    250       ASLPGMWERTLTIGSAGKTFS -> VSAAVLFGLGQPASLA
FT                                CGNGP (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009876.
FT   VAR_SEQ     251    422       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009877.
FT   CONFLICT    422    422       L -> LWP (in Ref. 3; AAH33685).
FT                                {ECO:0000305}.
FT   HELIX         8     10       {ECO:0000244|PDB:4WLH}.
FT   HELIX        18     26       {ECO:0000244|PDB:4WLH}.
FT   HELIX        44     55       {ECO:0000244|PDB:4WLH}.
FT   HELIX        58     61       {ECO:0000244|PDB:4WLH}.
FT   HELIX        70     84       {ECO:0000244|PDB:4WLH}.
FT   TURN         90     92       {ECO:0000244|PDB:4WLH}.
FT   STRAND       93     98       {ECO:0000244|PDB:4WLH}.
FT   HELIX        99    111       {ECO:0000244|PDB:4WLH}.
FT   STRAND      117    123       {ECO:0000244|PDB:4WLH}.
FT   HELIX       128    134       {ECO:0000244|PDB:4WLH}.
FT   STRAND      138    143       {ECO:0000244|PDB:4WLH}.
FT   STRAND      151    153       {ECO:0000244|PDB:3FVS}.
FT   STRAND      154    156       {ECO:0000244|PDB:1W7L}.
FT   HELIX       157    159       {ECO:0000244|PDB:4WLH}.
FT   HELIX       164    170       {ECO:0000244|PDB:4WLH}.
FT   STRAND      175    183       {ECO:0000244|PDB:4WLH}.
FT   TURN        185    187       {ECO:0000244|PDB:4WLH}.
FT   HELIX       193    206       {ECO:0000244|PDB:4WLH}.
FT   STRAND      209    213       {ECO:0000244|PDB:4WLH}.
FT   TURN        215    218       {ECO:0000244|PDB:4WLH}.
FT   HELIX       229    231       {ECO:0000244|PDB:4WLH}.
FT   TURN        233    235       {ECO:0000244|PDB:4WLH}.
FT   HELIX       236    238       {ECO:0000244|PDB:4WLH}.
FT   STRAND      239    244       {ECO:0000244|PDB:4WLH}.
FT   HELIX       245    249       {ECO:0000244|PDB:3FVS}.
FT   HELIX       252    254       {ECO:0000244|PDB:4WLH}.
FT   STRAND      257    260       {ECO:0000244|PDB:4WLH}.
FT   HELIX       263    274       {ECO:0000244|PDB:4WLH}.
FT   TURN        275    277       {ECO:0000244|PDB:4WLH}.
FT   HELIX       282    297       {ECO:0000244|PDB:4WLH}.
FT   TURN        298    300       {ECO:0000244|PDB:4WLH}.
FT   HELIX       305    325       {ECO:0000244|PDB:4WLH}.
FT   TURN        326    328       {ECO:0000244|PDB:4WLH}.
FT   STRAND      330    333       {ECO:0000244|PDB:4WLH}.
FT   STRAND      335    343       {ECO:0000244|PDB:4WLH}.
FT   HELIX       345    350       {ECO:0000244|PDB:4WLH}.
FT   HELIX       362    374       {ECO:0000244|PDB:4WLH}.
FT   HELIX       381    384       {ECO:0000244|PDB:4WLH}.
FT   HELIX       387    390       {ECO:0000244|PDB:4WLH}.
FT   TURN        391    393       {ECO:0000244|PDB:4WLJ}.
FT   STRAND      395    400       {ECO:0000244|PDB:4WLH}.
FT   HELIX       405    420       {ECO:0000244|PDB:4WLH}.
SQ   SEQUENCE   422 AA;  47875 MW;  EAEF2F5E77A9B55A CRC64;
     MAKQLQARRL DGIDYNPWVE FVKLASEHDV VNLGQGFPDF PPPDFAVEAF QHAVSGDFML
     NQYTKTFGYP PLTKILASFF GELLGQEIDP LRNVLVTVGG YGALFTAFQA LVDEGDEVII
     IEPFFDCYEP MTMMAGGRPV FVSLKPGPIQ NGELGSSSNW QLDPMELAGK FTSRTKALVL
     NTPNNPLGKV FSREELELVA SLCQQHDVVC ITDEVYQWMV YDGHQHISIA SLPGMWERTL
     TIGSAGKTFS ATGWKVGWVL GPDHIMKHLR TVHQNSVFHC PTQSQAAVAE SFEREQLLFR
     QPSSYFVQFP QAMQRCRDHM IRSLQSVGLK PIIPQGSYFL ITDISDFKRK MPDLPGAVDE
     PYDRRFVKWM IKNKGLVAIP VSIFYSVPHQ KHFDHYIRFC FVKDEATLQA MDEKLRKWKV
     EL
//
